Telehealth firm Hims & Hers Health said on Monday it plans to bring a generic version of Novo Nordisk's diabetes drug, liraglutide, to its platform in 2025.

Pfizer’s revenue from pharmaceuticals declined Pharmaceutical giant Pfizer is getting into the health care delivery business.

In interviews with Reuters, eight U.S. obesity specialists at universities and large health systems described a different experience. All of them said they are still seeing intense demand for ...

Expanded protocols promote early detection in high-risk patients and prevent hospital outbreaks of Candida auris.